Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler’s Syndrome

Marko BAREŠIĆ, Joško MITROVIĆ, Jadranka MOROVIĆ VERGLES, Branimir ANIĆ

DOI: 10.5606/ArchRheumatol.2016.6000

Issue: Volume 31 - Issue 4 - December 2016
6426 4536

Occurrence of Ulcerative Colitis in a Patient With Adult-Onset Still's Disease: Coincidence or Correlated

Yun Jung CHOI, Wan-hee YOO

DOI: 10.5606/ArchRheumatol.2017.6182

Issue: Volume 32 - Issue 3 - September 2017
4328 4917

Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab

Ben JACOBS, Ali JAWAD, Zozik FATTAH

DOI: 10.5606/ArchRheumatol.2018.6668

Issue: Volume 33 - Issue 3 - September 2018
2730 4091

Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis

In Ah CHOI, Sang Jin LEE, Won PARK, Sung Hwan PARK, Seung-cheol SHIM, Han Joo BAEK, Dae-Hyun YOO, Hyun Ah KIM, Soo Kon LEE, Yun Jong LEE, Young Eun PARK, Hoon-Suk CHA, Eun Young LEE, Eun Bong LEE, Yeong Wook SONG

DOI: 10.5606/ArchRheumatol.2018.6753

Issue: Volume 33 - Issue 4 - December 2018
3244 1788

Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis

Hua HUANG, Han CEN, Li ZHOU, Ting-hui WANG, Wen QIN, Bin-hua XIE, Dong-Mei XIAO, Xiu-Di WU, Hua-Xiang WU

DOI: 10.5606/ArchRheumatol.2019.7146

Issue: Volume 34 - Issue 4 - December 2019
1273 2115

Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra

Ufuk İLGEN, Orhan KÜÇÜKŞAHİN

DOI: 10.5606/ArchRheumatol.2020.7378

Issue: Volume 35 - Issue 1 - March 2020
2346 1397

Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?

Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY

DOI: 10.46497/ArchRheumatol.2020.7579

Issue: Volume 35 - Issue 4 - December 2020
1812 1621

Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review

Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR

DOI: 10.46497/ArchRheumatol.2021.7953

Issue: Volume 36 - Issue 1 - March 2021
2971 2762

Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience

Ferhat Demir, Eda Gürler, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2022.8998

Issue: Volume 37 - Issue 3 - September 2022
1180 970

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats

Dawei Lv, Xiaodong Zhao

DOI: 10.46497/ArchRheumatol.2023.9240

Issue: Volume 38 - Issue 1 - March 2023
743 831

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis

Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur

DOI: 10.46497/ArchRheumatol.2023.9636

Issue: Volume 38 - Issue 2 - June 2023
568 617